Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States
- PMID: 31008866
- DOI: 10.1097/MCG.0000000000001204
Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States
Abstract
Goal: The goal of this study was to evaluate disparities in hospital outcomes among inflammatory bowel disease (IBD) related hospitalizations in the United States with a focus on ethnicity-specific disparities.
Background: IBD-related hospitalizations contribute to significant morbidity and health care economic burden.
Methods: IBD-related hospitalizations (identified with ICD-9) among US adults were evaluated using 2007 to 2013 Nationwide Inpatient Sample. In-hospital mortality between groups was evaluated using χ and multivariate logistic regression models, stratified by Crohn's disease (CD) and ulcerative colitis (UC). Inflation-adjusted total hospitalization charges were evaluated using Student t test and multivariate linear regression.
Results: Among 224,500 IBD-related hospitalizations (77.8% CD, 22.2% UC), overall in-hospital mortality was low (0.99% CD, 0.78% UC). Although Hispanic UC patients had a trend towards higher odds of in-hospital mortality compared with non-Hispanic whites (OR, 1.54; 95% CI, 0.95-2.51; P=0.08), no ethnicity-specific disparities were observed in CD. From 2007 to 2013, mean inflation-adjusted hospitalization charges increased from $29,632 to $41,484, P<0.01 in CD and from $31,449 to $43,128 in UC, P<0.01. On multivariate regression, hospitalization charges in Hispanic CD patients were $9302 higher (95% CI, 7910-10,694; P<0.01) and in Asian CD patients were $7665 higher (95% CI, 4859-10,451; P<0.001) than non-Hispanic whites. Compared with non-Hispanic white UC patients, Hispanics had $6910 (95% CI, $4623-$9197) higher charges and African Americans had $3551 lower charges (95% CI, -$5002 to -$2101).
Conclusions: Although most IBD hospitalizations in the United States were among non-Hispanic whites, Hispanic patients with IBD had a trend towards higher in-hospital mortality and contributed to significantly higher hospitalization charges.
Similar articles
-
Clostridium difficile co-infection in inflammatory bowel disease is associated with significantly increased in-hospital mortality.Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1041-1046. doi: 10.1097/MEG.0000000000001185. Eur J Gastroenterol Hepatol. 2018. PMID: 29894325
-
Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.Dig Dis Sci. 2021 Dec;66(12):4169-4177. doi: 10.1007/s10620-020-06818-x. Epub 2021 Jan 25. Dig Dis Sci. 2021. PMID: 33492533
-
Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.Dig Dis Sci. 2020 Feb;65(2):406-415. doi: 10.1007/s10620-019-05809-x. Epub 2019 Sep 5. Dig Dis Sci. 2020. PMID: 31489564
-
Significant Racial and Ethnic Disparities Exist in Health Care Utilization in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Inflamm Bowel Dis. 2024 Mar 1;30(3):470-481. doi: 10.1093/ibd/izad045. Inflamm Bowel Dis. 2024. PMID: 36975373
-
Hispanics and inflammatory bowel disease.Inflamm Bowel Dis. 2015 May;21(5):1214-8. doi: 10.1097/MIB.0000000000000300. Inflamm Bowel Dis. 2015. PMID: 25581831 Review.
Cited by
-
Higher Inpatient Racial and Ethnic Diversity Is Associated with Better Outcomes in Hispanic and Native American Patients for Gastrointestinal Diseases.Dig Dis Sci. 2025 Jun;70(6):1986-1995. doi: 10.1007/s10620-025-09004-z. Epub 2025 Apr 8. Dig Dis Sci. 2025. PMID: 40198527
-
Prognostication in inflammatory bowel disease.Front Med (Lausanne). 2022 Oct 6;9:1025375. doi: 10.3389/fmed.2022.1025375. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36275829 Free PMC article. Review.
-
Prolonged time to treatment of biologics in inflammatory bowel disease: disparities from a retrospective study in a tertiary referral centre in the UK.BMC Gastroenterol. 2025 May 9;25(1):352. doi: 10.1186/s12876-025-03909-9. BMC Gastroenterol. 2025. PMID: 40346554 Free PMC article.
-
Racial disparity in inflammatory bowel disease-related complications: a nationwide cohort study.Ann Gastroenterol. 2025 May-Jun;38(3):294-305. doi: 10.20524/aog.2025.0958. Epub 2025 Apr 17. Ann Gastroenterol. 2025. PMID: 40371211 Free PMC article.
-
Evaluation of Racial/Ethnic Disparities in the Surgical Management of Inflammatory Bowel Disease.J Gastrointest Surg. 2022 Dec;26(12):2559-2568. doi: 10.1007/s11605-022-05483-x. Epub 2022 Oct 17. J Gastrointest Surg. 2022. PMID: 36253503
References
-
- Kappelman MD, Moore KR, Allen JK, et al. Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci. 2013;58:519–525.
-
- Kappelman MD, Porter CQ, Galanko JA, et al. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:62–68.
-
- Monstad I, Hovde Ø, Solberg IC, et al. Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies. Ann Gastroenterol. 2014;27:95–104.
-
- Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431–440.
-
- Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–1438.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical